The average one-year price target for MIRA Pharmaceuticals (NasdaqCM:MIRA) has been revised to $3.06 / share. This is a decrease of 83.10% from the prior estimate of $18.10 dated September 27, 2025.
Malawi breaking news publishing 24 hours a day news about Malawi, Malawi Business, Malawi Tourism, Malawi Politics, Malawi News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback